📜 Post with us on Reddit
📝 Create a new article
🏭 Create a company page
🇬🇧 - in English
🇫🇷 - en Français (FR)
🇵🇹 - em Português (PT)
🇩🇪 - auf Deutsch (DE)
🇯🇵 - 日本語で (JA)
Sponsored articles

You can edit almost every page by Creating an account and confirming your email.

Trimi Health

From EverybodyWiki Bios & Wiki



Trimi Health
Private
ISIN🆔
IndustryTelemedicine; Pharmaceutical compounding
Founded 📆May 2024; 2 years ago (2024-05)
Founder 👔
Area served 🗺️
Products 📟 Compounded semaglutide; Compounded tirzepatide
Members
Number of employees
🌐 Websitetrytrimi.com
📇 Address
📞 telephone

Trimi Health is an American telehealth company that operates

within a category of online providers that emerged in 2023–2024 dispensing

compounded versions of [[Glucagon-like peptide-1 receptor

agonist|GLP-1 receptor agonist]] medications during a federal shortage of the

branded products.[1][2] The company

is headquartered in New York City and was incorporated in May 2024.Cite error: Invalid parameter in <ref> tag[3]

The shortage and resulting compounding window produced a substantial industry of

online telehealth platforms — including Hims & Hers Health, Ro, Henry Meds, Mochi

Health, and Trimi Health — that paired licensed prescribers with 503A pharmacy

partners. The FDA has repeatedly issued public warnings about consumer-safety risks

associated with this category, including dosing errors, salt-form contamination, and

online sellers operating outside legitimate medical practice.[4] The agency removed tirzepatide from the shortage list in late 2024,

narrowing the regulatory basis for compounding it, and has continued to issue

guidance affecting which 503A activities remain permitted.<ref name="fda-shortage"/>

Operations

Clinical infrastructure

Clinical care on the platform is delivered by medical doctors and other licensed

prescribers contracted through Beluga Health, a multistate [[management services

organization]] (MSO) that serves as a clinician network for telehealth platforms.

[5] Beluga Health holds LegitScript healthcare merchant

certification, is ISO/IEC 27001 and SOC 2 compliant, and licenses

prescribers in all 50 U.S. states and Washington, D.C.[5]

Provider profiles published on the Trimi Health website include Asad Niazi, M.D.,

M.P.H., listed as a prescribing clinician within the Beluga Health network.[6]Trimi Health itself holds active LegitScript Healthcare Merchant Certification,

a third-party compliance program used by major advertising and payment platforms to

verify that telehealth merchants meet applicable U.S. legal and regulatory

standards.[7]

Subsciption Model

Trimi Health operates on a recurring-subscription model with annual, semi-annual,

quarterly, and monthly billing options. The plans bundle medication, clinician

access, and shipping into a single monthly price.[8][9] Pricing varies by plan length and by which active ingredient is

prescribed; reviewers have noted the company's annual-billing price points are below

the typical range for comparable compounded-GLP-1 telehealth services.[8][10]

Reception and Criticism

Independent coverage of Trimi Health has been limited and primarily appears on

consumer lifestyle and health blogs rather than mainstream business or medical

press.

A 2026 long-form review by the consumer health publication MindBodyDad examined the

company's intake flow, clinician interaction, pricing, and pharmacy supply chain.

The reviewer described the model as a representative example of compounded-GLP-1

telehealth, identified the use of named 503A pharmacy partners as a transparency

factor, and concluded that the company was "a reliable option" within the category.

The same review also noted negative themes from third-party patient comments, citing

reports of "inconsistencies in some customer service experiences.

"[11] The reviewer characterized those reports as anecdotal.

The Cinnamon Hollow listed Trimi Health among "safe weight-loss prescription"

providers in a 2026 feature about online compounded GLP-1 options.[12] GenTwenty included the company in a 2026 roundup of online

health-management providers.[13]

The broader category in which Trimi Health operates has been the subject of

consumer-safety warnings from the FDA, including alerts about dosing errors with

compounded semaglutide and concerns about online sellers marketing compounded GLP-1

medications outside legitimate medical practice. Trimi Health has not been the

subject of such an FDA notice as of mid-2026.[14]


Regulatory Framework

The compounded medications dispensed through Trimi Health are not FDA-approved drug

products. They are prepared under Section 503A of the [[Federal

Food, Drug, and Cosmetic Act]], which permits state-licensed pharmacies to preparepatient-specific compounded medications in response to a valid prescription from a

licensed prescriber.[15] The active pharmaceutical ingredients —

semaglutide and tirzepatide — are themselves FDA-approved within the commercial

finished products marketed by Novo Nordisk and Eli Lilly and Company.[16][17]

Pivotal clinical evidence supporting the use of GLP-1 receptor agonists for chronic

weight management comes from manufacturer-sponsored trials of the branded products.

The STEP 1 trial, published in The New England Journal of Medicine in 2021,

reported a mean weight reduction of 14.9% over 68 weeks among adults with overweight

or obesity receiving once-weekly semaglutide 2.4 mg.[18] The

SURMOUNT-1 trial, published in the same journal in 2022, reported mean weight

reductions of 15.0–20.9% across dose levels for tirzepatide.[19]

The trials evaluated the branded products manufactured by Novo Nordisk and Eli

Lilly; no equivalent clinical trial data exists for the compounded preparations sold

by Trimi Health or comparable telehealth platforms.[18][19]

See also

  • Compounded medication

References

<div class="reflist columns references-column-width" style="-moz-column-width: [5] [20] [21] [22] [7] [23] [15] [24] [14] [18] [19] [16] [17] }}

External links

Category:Telehealth companies of the United States Category:Companies based in New York City Category:American companies established in 2024 Category:Pharmaceutical compounding Category:Health care companies established in 2024; -webkit-column-width: [5] [20] [21] [22] [7] [23] [15] [24] [14] [18] [19] [16] [17] }}

External links

Category:Telehealth companies of the United States Category:Companies based in New York City Category:American companies established in 2024 Category:Pharmaceutical compounding Category:Health care companies established in 2024; column-width: [5] [20] [21] [22] [7] [23] [15] [24] [14] [18] [19] [16] [17] }}

External links

Category:Telehealth companies of the United States Category:Companies based in New York City Category:American companies established in 2024 Category:Pharmaceutical compounding Category:Health care companies established in 2024; list-style-type: decimal;">

  1. ↑ Cite error: Invalid <ref> tag; no text was provided for refs named fda-shortage3
  2. ↑ Cite error: Invalid <ref> tag; no text was provided for refs named mindbodydad3
  3. ↑ Cite error: Invalid <ref> tag; no text was provided for refs named fda-503a3
  4. ↑ Cite error: Invalid <ref> tag; no text was provided for refs named fda- concerns
  5. ↑ 5.0 5.1 5.2 [https://www.mindbodydad.com/body/an-in- depth-review-of-trimi-health "An In-Depth Review of Trimi Health"] Check |url= value (help). MindBodyDad. 5 May 2026. Retrieved 11 May 2026. line feed character in |url= at position 40 (help)
  6. ↑ Cite error: Invalid <ref> tag; no text was provided for refs named trimi-providers
  7. ↑ 7.0 7.1 [https://www.legitscript.com/websites/?checker _ keywords=trytrimi.com "LegitScript Healthcare Merchant Certification — trytrimi.com"] Check |url= value (help). LegitScript. Unknown parameter |access- date= ignored (help); line feed character in |url= at position 46 (help); line feed character in |title= at position 32 (help)
  8. ↑ 8.0 8.1 Cite error: Invalid <ref> tag; no text was provided for refs named mindbodydad4
  9. ↑ Cite error: Invalid <ref> tag; no text was provided for refs named gentwenty3
  10. ↑ Cite error: Invalid <ref> tag; no text was provided for refs named cinnamonhollow3
  11. ↑ Cite error: Invalid <ref> tag; no text was provided for refs named mindbodydad5
  12. ↑ Cite error: Invalid <ref> tag; no text was provided for refs named cinnamonhollow4
  13. ↑ Cite error: Invalid <ref> tag; no text was provided for refs named gentwenty4
  14. ↑ 14.0 14.1 [https://www.fda.gov/drugs/postmarket-drug-safety-information- patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes- or-weight-loss "Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss"] Check |url= value (help). U.S. Food and Drug Administration. Retrieved 11 May 2026. line feed character in |website= at position 19 (help); line feed character in |url= at position 62 (help); line feed character in |title= at position 35 (help)
  15. ↑ 15.0 15.1 [https://www.fda.gov/drugs/human-drug-compounding/section-503a-federal-food- drug-and-cosmetic-act "Section 503A of the Federal Food, Drug, and Cosmetic Act"] Check |url= value (help). U.S. Food and Drug Administration. Retrieved 11 May 2026. line feed character in |url= at position 76 (help); line feed character in |title= at position 44 (help)
  16. ↑ 16.0 16.1 [https://www.accessdata.fda.gov/drugsatfda _ docs/label/2021/215256s000lbl.pdf "Wegovy (semaglutide) Prescribing Information"] Check |url= value (help) (PDF). U.S. Food and Drug Administration. Retrieved 11 May 2026. line feed character in |url= at position 42 (help)
  17. ↑ 17.0 17.1 [https://www.accessdata.fda.gov/drugsatfda _ docs/label/2023/217806s000lbl.pdf "Zepbound (tirzepatide) Prescribing Information"] Check |url= value (help) (PDF). U.S. Food and Drug Administration. Retrieved 11 May 2026. line feed character in |url= at position 42 (help); line feed character in |title= at position 35 (help)
  18. ↑ 18.0 18.1 18.2 Wilding, John P.H.; et al. (18 March 2021). "Once-Weekly Semaglutide in Adults with Overweight or Obesity". New England Journal of Medicine. 384 (11): 989–1002. doi:10.1056/NEJMoa2032183. PMID 33567185 Check |pmid= value (help). line feed character in |title= at position 12 (help); line feed character in |journal= at position 23 (help)
  19. ↑ 19.0 19.1 19.2 Jastreboff, Ania M.; et al. (21 July 2022). "Tirzepatide Once Weekly for the Treatment of Obesity". New England Journal of Medicine. 387 (3): 205–216. doi:10.1056/NEJMoa2206038. PMID 35658024 Check |pmid= value (help). line feed character in |journal= at position 12 (help)
  20. ↑ [https://thecinnamonhollow.com/safe- weight-loss-prescriptions-2026/ "Safe Weight Loss Prescriptions in 2026"] Check |url= value (help). The Cinnamon Hollow. 2026. Retrieved 11 May 2026. line feed character in |url= at position 36 (help)
  21. ↑ [https://gentwenty.com/5-online-providers-for- health-management/ "5 Online Providers for Health Management"] Check |url= value (help). GenTwenty. 2026. Retrieved 11 May 2026. line feed character in |url= at position 46 (help)
  22. ↑ "Trimi Health (Q139701245)". Wikidata. Retrieved 11 May 2026.
  23. ↑ "Pharmacy License Verification — VialsRx (License #35264)". Texas State Board of Pharmacy. Retrieved 11 May 2026. line feed character in |title= at position 32 (help)
  24. ↑ "FDA Drug Shortages". U.S. Food and Drug Administration. Retrieved 11 May 2026. line feed character in |website= at position 14 (help)

{Reflist|refs=

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

}}

External links


This article "Trimi Health" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Trimi Health. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

  1. ↑ [https://www.mindbodydad.com/body/an-in- depth-review-of-trimi-health "An In-Depth Review of Trimi Health"] Check |url= value (help). MindBodyDad. 5 May 2026. Retrieved 11 May 2026. line feed character in |url= at position 40 (help)
  2. ↑ "Safe Weight Loss Prescriptions in 2026". The Cinnamon Hollow. 2026. Retrieved 11 May 2026.
  3. ↑ [https://gentwenty.com/5-online-providers-for- health-management/ "5 Online Providers for Health Management"] Check |url= value (help). GenTwenty. 2026. Retrieved 11 May 2026. line feed character in |url= at position 46 (help)
  4. ↑ "Trimi Health (Q139701245)". Wikidata. Retrieved 11 May 2026.
  5. ↑ [https://www.legitscript.com/websites/?checker _ keywords=trytrimi.com "LegitScript Healthcare Merchant Certification — trytrimi.com"] Check |url= value (help). LegitScript. Unknown parameter |access- date= ignored (help); line feed character in |title= at position 32 (help); line feed character in |url= at position 46 (help)
  6. ↑ "Pharmacy License Verification — VialsRx (License #35264)". Texas State Board of Pharmacy. Retrieved 11 May 2026. line feed character in |title= at position 32 (help)
  7. ↑ "Provider directory: Asad Niazi, M.D., M.P.H." Trimi Health. Retrieved 11 May 2026. line feed character in |title= at position 38 (help); line feed character in |access-date= at position 7 (help); Check date values in: |access-date= (help)
  8. ↑ [https://www.fda.gov/drugs/human-drug-compounding/section-503a-federal-food- drug-and-cosmetic-act "Section 503A of the Federal Food, Drug, and Cosmetic Act"] Check |url= value (help). U.S. Food and Drug Administration. Retrieved 11 May 2026. line feed character in |url= at position 76 (help); line feed character in |title= at position 44 (help)
  9. ↑ "FDA Drug Shortages". U.S. Food and Drug Administration. Retrieved 11 May 2026. line feed character in |website= at position 14 (help)
  10. ↑ Wilding, John P.H.; Batterham, Rachel L.; Calanna, Salvatore; Davies, Melanie; Van Gaal, Luc F.; Lingvay, Ildiko; McGowan, Barbara M.; Rosenstock, Julio; Tran, Marie T.D.; Wadden, Thomas A.; Wharton, Sean; Yokote, Koutaro; Zeuthen, Niels; Kushner, Robert F. (18 March 2021). "Once-Weekly Semaglutide in Adults with Overweight or Obesity". New England Journal of Medicine. 384 (11): 989–1002. doi:10.1056/NEJMoa2032183. PMID 33567185 Check |pmid= value (help). line feed character in |pages= at position 5 (help); line feed character in |journal= at position 4 (help)
  11. ↑ Jastreboff, Ania M.; Aronne, Louis J.; Ahmad, Naga N.; Wharton, Sean; Connery, Lisa; Alves, Breno; Kiyosue, Arihiro; Zhang, Shuyu; Liu, Bing; Bunck, Mathijs C.; Stefanski, Adam (21 July 2022). "Tirzepatide Once Weekly for the Treatment of Obesity". New England Journal of Medicine. 387 (3): 205–216. doi:10.1056/NEJMoa2206038. PMID 35658024 Check |pmid= value (help). line feed character in |date= at position 8 (help); line feed character in |title= at position 24 (help); Check date values in: |date= (help)
  12. ↑ [https://www.accessdata.fda.gov/drugsatfda _ docs/label/2021/215256s000lbl.pdf "Wegovy (semaglutide) Prescribing Information"] Check |url= value (help) (PDF). U.S. Food and Drug Administration. Retrieved 11 May 2026. line feed character in |url= at position 42 (help)
  13. ↑ [https://www.accessdata.fda.gov/drugsatfda _ docs/label/2023/217806s000lbl.pdf "Zepbound (tirzepatide) Prescribing Information"] Check |url= value (help) (PDF). U.S. Food and Drug Administration. Retrieved 11 May 2026. line feed character in |url= at position 42 (help); line feed character in |title= at position 35 (help)

Retrieved from "https://en.everybodywiki.com/index.php?title=Trimi_Health&oldid=6148405"
License CC BY-SA 3.0
Powered by MediaWiki